What is SolvHealth?
Founded in 2016 and headquartered in San Francisco, SolvHealth operates a sophisticated mobile-friendly platform that facilitates same-day doctor appointments at urgent care clinics. The company was established by a team of product and engineering veterans from leading consumer technology firms, including Trulia, with the explicit goal of bringing transparency and convenience to the fragmented healthcare system. By integrating seamlessly with existing health systems, SolvHealth provides a critical digital interface that improves operational efficiency for clinics while simultaneously enhancing the patient experience through streamlined booking and reduced wait times.
How much funding has SolvHealth raised?
SolvHealth has raised a total of $78.3M across 3 funding rounds:
Series A
$6.3M
Series B
$27M
Series C
$45M
Series A (2017): $6.3M with participation from Benchmark Capital, Aspect Ventures, and Ensemble Labs
Series B (2020): $27M led by Greylock Partners, Benchmark, MultiCare Health System, Acrew Capital, and Light Street Capital
Series C (2021): $45M supported by Corner Ventures, Greylock Partners, Benchmark Capital, and Acrew Capital Management
Key Investors in SolvHealth
Benchmark Capital
A premier venture capital firm known for its early-stage investments in transformative technology companies and its long-term commitment to founder-led businesses.
Greylock Partners
One of the oldest U.S. venture capital firms, Greylock focuses on early-stage technology companies in sectors such as consumer internet, enterprise software, and AI.
Acrew Capital Management
A multidisciplinary venture capital firm that provides support to companies from Seed to growth stages, emphasizing emotional intelligence and diverse perspectives in their investment strategy.
What's next for SolvHealth?
With the support of major institutional backers, SolvHealth is well-positioned to scale its operations and deepen its integration within the broader healthcare ecosystem. The current lifecycle stage, characterized by major enterprise-level funding, suggests a strategic pivot toward market dominance and the potential for further product diversification. Future initiatives will likely focus on expanding the network of participating clinics and enhancing the platform's predictive capabilities to better manage patient flow. As the company matures, its ability to maintain high-quality service standards while scaling will be the primary driver of its long-term valuation and impact on the digital health landscape.
See full SolvHealth company page
